23andMe Holding Co. ME:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/26/23 EST
2.42UNCH (UNCH)
Volume
8,167
Close
2.42UNCH (UNCH)
Volume
1,112,489
52 week range
2.02 - 6.31
Loading...
  • Open2.40
  • Day High2.46
  • Day Low2.35
  • Prev Close2.42
  • 52 Week High6.31
  • 52 Week High Date08/11/22
  • 52 Week Low2.02
  • 52 Week Low Date01/06/23

Key Stats

  • Market Cap1.102B
  • Shares Out455.48M
  • 10 Day Average Volume2.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change12.04

KEY STATS

  • Open2.40
  • Day High2.46
  • Day Low2.35
  • Prev Close2.42
  • 52 Week High6.31
  • 52 Week High Date08/11/22
  • 52 Week Low2.02
  • 52 Week Low Date01/06/23
  • Market Cap1.102B
  • Shares Out455.48M
  • 10 Day Average Volume2.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change12.04

RATIOS/PROFITABILITY

  • EPS (TTM)-1.19
  • P/E (TTM)-2.03
  • Fwd P/E (NTM)-3.79
  • EBITDA (TTM)-287.814M
  • ROE (TTM)-42.54%
  • Revenue (TTM)297.622M
  • Gross Margin (TTM)46.40%
  • Net Margin (TTM)-105.68%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/10/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 23andMe Holding Co.

Content From Our Affiliates

Profile

MORE
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company's segments include Consumer & Research Services and Therapeutics. The Consumer & Research Services segment comprises its Personal Genome Service (PGS), telehealth business, and research services. Its PGS service provides customers with a suite of genetic reports, including information on customers genetic ancestral origins, personal genetic health risks, and chances of passing on...
Anne Wojcicki
Chief Executive Officer, Director
Paul Johnson
Chief Operating Officer - Consumer
Steve Schoch
Chief Accounting Officer
Address
349 Oyster Point Boulevard
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
LGND
Ligand Pharmaceuticals Inc
69.72UNCHUNCH
ICPT
Intercept Pharmaceuticals Inc
18.37UNCHUNCH
KNSA
Kiniksa Pharmaceuticals Ltd
13.77UNCHUNCH
XNCR
Xencor Inc
31.78UNCHUNCH
CHRS
Coherus BioSciences Inc
8.35UNCHUNCH